U.S. COVID-19 Vaccine Product Information

The Advisory Committee on Immunization Practices will be meeting to discuss recommendations for the recently authorized Moderna COVID-19 Vaccine for ages 6-17 years on June 23rd. The Interim Clinical Considerations and associated materials for healthcare providers will be updated with applicable guidance soon after that meeting.

Find a suite of information and materials that are needed for each specific COVID-19 vaccine that cover administration, storage and handling, safety, and reporting.

Page last reviewed: May 26, 2022